)
Hetal Marble
Head of Commercial,
ImmutoScientific
Hetal Marble is Head of Commercial at Immuto Scientific, driving licensing, business development, marketing, and product strategy for the company’s protein characterization technologies. She has led commercial growth and product launches across diagnostics, biomarkers, and research tools at companies like Quanterix, Promega, and Pall Biotech. At MGH’s Center for Integrated Diagnostics, she built a successful in-house CRO focused on precision biomarkers. With a Ph.D. from Brown University and two U.S. patents, Hetal remains engaged in the scientific community through leadership roles in AMP and Women in Bio and as a contributing author for the Mayo Clinic Press.
Sessions
-
19-Feb-2025Opening Address & Keynote Presentation: A Structure-Guided Path to Efficacious Antibodies for Precision Therapy
-
19-Feb-2025Stop shooting in the dark: Leveraging early structural insights to power rational antibody lead design & optimization
-
19-Feb-2025Lead Identification & Optimization: Empirical, Solution-State Epitope/Paratope Interactions to Constrain In Silico Models for Antibody Design and Targeted Engineering